Blog
Q&A with Chief Scientist Francesca Cormack
We caught up with our Chief Scientist Francesca Cormack ahead of her AAIC 2022 session on virtual clinical trials. Here Francesca tells us more about her career journey, what she is currently focusing on and why virtual clinical trials are such an exciting area to be working in.
Validating digital assessments for real-world testing
The power of remote assessments is the flexibility in when and where they can be administered. However, with this increased flexibility comes a responsibility to collect data at a frequency that is meaningful but not burdensome for the patient. This article will cover how to navigate this tricky process and strike the balance.
New virtual study to measure stress recovery in frontline health workers caring for COVID-19 patient
Cambridge Cognition is pleased to announce a collaboration with 4YouandMe and The Center for International Emergency Medical Services to investigate the utility of wearables and mobile phones for measuring stress recovery in frontline health workers caring for COVID-19 positive patients.
Remote cognitive testing: what are the scientific and operational considerations?
Remote testing solutions for clinical trials and academic research are increasingly being adopted resulting in time and cost savings for clinical research studies and reduced participation burden for study patients. However, not every study is suitable for this medium. In this article we cover the scientific and operational factors for deciding whether to use remote cognitive testing in an upcoming trial.
COVID-19 and Virtual Trials: What does the FDA’s guidance mean for drug development?
The FDA have released guidance urging clinical trials to go virtual where possible in response to the COVID-19 pandemic – so what are the best methods for ensuring patient safety and trial integrity during this transition? In this article, we will discuss some of the important aspects to consider when taking a therapeutic trial from the clinic to the patient’s home.
The full FDA Guidance on Conduct of Clinical Trials of Medical Products During the COVID-19 Pandemic is available here.
Feasibility of automated voice based cognitive assessment on a consumer voice platform
Exploring the use of automated voice based cognitive assessments on consumer voice platforms.
How new technologies are expanding the reach of cognitive assessment
Dr Jenny Barnett, Chief Scientific Officer for Cambridge Cognition reviews how the rise of touchscreen technology has enabled the expansion of cognitive assessment.
